Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

Six deaths reported this past week in McLeod County were attributed to COVID-19, according to data from the Minnesota Department of Health. It was the deadliest week of the pandemic since last ...

More than 1,000 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

Moderna has reported preliminary clinical ... that it is too early to consider widespread use of a second COVID-19 vaccine booster dose in the EU.

researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, Norway, and North Macedonia. Read more here.

A booster shot is an additional dose of a COVID-19 vaccine that enhances its ... in the world due to agreements with Pfizer/BioNTech, Moderna, AstraZeneca, Medicago, Sanofi-GlaxoSmithKline ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting ...

Moderna stock has been under pressure amid declining sales of its COVID-19 vaccine ... in clinical trials that could be the booster shot the stock needs to generate a rebound.